98%
921
2 minutes
20
Background: Coronary microvascular dysfunction (CMD) predicts poor prognosis in patients with coronary artery disease (CAD). However, the impact of intravascular lithotripsy (IVL) on CMD remains unclear, and no studies have directly compared IVL and rotational atherectomy (RA) in the context of CMD.
Objective: This study aimed to evaluate CMD, as indicated by angiographic microvascular resistance (AMR), in patients undergoing IVL- or RA-assisted PCI for heavily calcified coronary lesions.
Methods: This multicenter retrospective cohort study enrolled patients underwent either RA- or IVL-assisted percutaneous coronary intervention (PCI) at three centers. Propensity score matching (1:2) was performed to control for potential bias. The primary outcomes included the post-PCI AMR values and CMD incidence. The secondary outcomes included peri-procedural adverse events (PPAEs).
Results: A total of 377 patients were registered, and 210 propensity-matched patients (140 RA vs. 70 IVL) were analyzed. Pre-PCI AMR was similar between the groups (RA 1.24 ± 0.53 vs. IVL 1.28 ± 0.50, = 0.615). Following PCI, AMR was significantly higher in the RA group compared to IVL (2.43 ± 0.35 vs. 2.26 ± 0.50, = 0.015), while CMD incidence was comparable (RA 32.9% vs. IVL 27.1%, = 0.398). In addition, the PPAEs rates were lower in the IVL group but the difference showed no statistical significance (27.9% vs. 17.1%, = 0.088).
Conclusions: IVL demonstrates less microvascular dysfunction compared to RA, as indicated by lower post-PCI AMR. These findings suggest that IVL may offer advantages in preserving coronary microvascular function across various clinical scenarios when both techniques are equally available and applicable, but further large-scale prospective studies are needed to verify these results.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12092434 | PMC |
http://dx.doi.org/10.3389/fcvm.2025.1560743 | DOI Listing |
Medicine (Baltimore)
September 2025
Department of Gynecology and Obstetrics, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Rationale: Intravascular/intravenous leiomyomatosis (IVL) is a rare benign smooth muscle cell tumor with malignant biological behavior. The early diagnosis of IVL is challenging, and the range of treatment options is extensive.
Patient Concerns: Herein, we present 2 cases of IVL that present markedly different clinical presentations.
Ann Vasc Dis
August 2025
Department of Cardiovascular Surgery, Nara Prefecture General Medical Center, Nara, Nara, Japan.
Intravenous leiomyomatosis with intracardiac extension is a rare benign tumor originating from uterine smooth muscle. A 50-year-old woman presented with a cardiac mass 3 years after hysterectomy. Imaging revealed a tumor extending from the right internal iliac vein to the right atrium.
View Article and Find Full Text PDFCardiol J
September 2025
Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne, United Kingdom.
Background: Cumulative data has highlighted the efficacy of intra-vascular lithotripsy (IVL) in patients with stent failure (SF). However, it remains unclear whether the effectiveness of IVL, and subsequent clinical outcomes, are influenced by the timing of SF. We aimed to evaluate the outcomes of patients with SF undergoing IVL according to the age of index stent implantation.
View Article and Find Full Text PDFBMC Cardiovasc Disord
September 2025
Department of Applied Mathematics, Faculty of Electrical Engineering and Computer Science, VSB-Technical University of Ostrava, Ostrava, Czech Republic.
Background: This prospective randomized study compares the efficacy of novel intravascular lithotripsy (IVL) to the standard preparation of calcified coronary lesions based on rotational atherectomy (RA).
Methods: A total of 50 patients with 52 calcified lesions were enrolled in the study and randomized 1:1 to be treated with IVL or RA followed by drug-eluting stent (DES) implantation. The procedural success was chosen as a primary endpoint and the 12-month late lumen loss (LLL) as measured by quantitative coronarography, the incidence of binary in-stent restenosis (ISR), 12-month major adverse cardiac events (MACE) and target lesion failure (TLF) served as secondary angiographic and clinical endpoints.
Struct Heart
August 2025
Gagnon Cardiovascular Institute, Atlantic Health System, Morristown, New Jersey, United States.
Background: Severe calcific mitral stenosis is common and therapeutically challenging. Intravascular lithotripsy (IVL) can facilitate percutaneous balloon mitral valvuloplasty in patients not amenable to conventional therapies. We describe a modified technique using larger IVL balloons to ensure maximal annular contact and delivery of ultrasonic shockwaves to restore mitral leaflet pliability and reduce transvalvular gradients without the need for noncompliant valvuloplasty balloons.
View Article and Find Full Text PDF